JBIO
Jade Biosciences·NASDAQ
--
--(--)
--
--(--)
JBIO fundamentals
During Q4 2025, Jade Biosciences (JBIO) reported revenue of --, a YoY change of 0.00%. Net income was -31.93M, a YoY change of -6.04%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 1.36M -- | 1.63M -- | 2.24M -- | 3.66M -- | 2.78M +104.71% | 5.77M +255.32% | 6.20M +176.42% | 8.27M +125.72% | 11.02M +296.37% | 12.21M +111.55% | 14.15M +128.26% | 15.85M +91.73% | 17.64M +60.08% | 20.34M +66.48% | 21.37M +50.99% | 22.07M +39.20% | 24.62M +39.57% | -24.03M -218.15% | 14.96M -29.97% | 19.98M -9.44% | 3.39M -86.24% | 27.78M +215.61% | 27.40M +83.10% | 34.98M +75.04% | 93.55M -- |
Selling, General and Administrative Expenses | 152.00K -- | 154.00K -- | 277.00K -- | 366.00K -- | 584.00K +284.21% | 1.45M +839.61% | 2.78M +904.33% | 3.22M +780.33% | 3.76M +544.52% | 3.85M +166.21% | 3.37M +21.10% | 3.63M +12.69% | 4.15M +10.28% | 4.30M +11.68% | 4.48M +33.10% | 4.25M +17.13% | 4.54M +9.32% | -4.03M -193.58% | 1.38M -69.13% | 2.41M -43.38% | 3.39M -25.36% | 5.23M +229.93% | 5.39M +289.52% | 6.44M +167.36% | 20.45M -- |
General and Administrative Expenses | 152.00K -- | -- -- | -- -- | 949.00K -- | -- -- | -- -- | -- -- | 8.04M +746.68% | -- -- | -- -- | -- -- | 14.62M +81.89% | -- -- | -- -- | 4.48M -- | 4.25M -70.90% | 4.54M -- | -4.03M -- | 1.38M -69.13% | 2.41M -43.38% | 3.39M -25.36% | 5.23M +229.93% | 5.39M +289.52% | 6.44M +167.36% | 20.45M -- |
Research and Development Expenses | 1.21M -- | 1.47M -- | 1.97M -- | 3.30M -- | 2.20M +82.09% | 4.33M +194.15% | 3.42M +73.86% | 5.05M +53.05% | 7.25M +230.37% | 8.36M +93.27% | 10.78M +215.48% | 12.22M +142.19% | 13.49M +85.91% | 16.03M +91.73% | 16.88M +56.58% | 17.81M +45.76% | 20.08M +48.87% | -20.00M -224.75% | 13.58M -19.56% | 17.57M -1.34% | 0 -100.00% | 22.55M +212.72% | 22.01M +62.06% | 28.54M +62.40% | 73.10M -- |
Operating Income | -1.36M -- | -1.63M -- | -2.24M -- | -3.66M -- | -2.78M -104.71% | -5.77M -255.32% | -6.20M -176.42% | -8.27M -125.72% | -11.02M -296.37% | -12.21M -111.55% | -14.15M -128.26% | -15.85M -91.73% | -17.64M -60.08% | -20.34M -66.48% | -21.37M -50.99% | -22.07M -39.20% | -24.62M -39.57% | 24.03M +218.15% | -14.96M +29.97% | -19.98M +9.44% | -3.39M +86.24% | -27.78M -215.61% | -27.40M -83.10% | -34.98M -75.04% | -93.55M -- |
Non-Operating Income (Loss) | -78.00K -- | -577.00K -- | -64.00K -- | -3.00K -- | -1.00K +98.72% | -1.00K +99.83% | 16.00K +125.00% | 48.00K +1700.00% | 109.00K +11000.00% | 224.00K +22500.00% | 564.00K +3425.00% | 855.00K +1681.25% | 1.12M +926.61% | 1.31M +485.27% | 1.80M +220.04% | 1.71M +99.88% | 1.43M +27.97% | -1.43M -209.23% | -1.31M -172.69% | -10.13M -692.69% | 869.00K -39.32% | -4.36M -204.19% | 2.23M +269.66% | 3.10M +130.65% | 1.84M -- |
Gain (Loss) on Change in Fair Value | -40.00K -- | -- -- | -- -- | -644.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -1.70M -- | -10.90M -- | -- -- | -6.18M -- | 0 +100.00% | 0 +100.00% | -- -- |
Other Non-Operating Income (Loss) | 0 -- | -540.00K -- | -64.00K -- | 641.00K -- | -1.00K -- | -3.00K +99.44% | -- -- | 1.00K -99.84% | -- -- | -6.00K -100.00% | 4.00K -- | -77.00K -7800.00% | -1.00K -- | -1.00K +83.33% | 1.00K -75.00% | 0 +100.00% | -3.00K -200.00% | 3.00K +400.00% | 0 -100.00% | 0 -- | -2.00K +33.33% | -- -- | -28.00K -- | 20.00K -- | -- -- |
Net Interest Expense | 38.00K -- | 37.00K -- | 0 -- | 0 -- | 0 -100.00% | -2.00K -105.41% | -16.00K -- | -47.00K -- | -109.00K -- | -230.00K -11400.00% | -560.00K -3400.00% | -932.00K -1882.98% | -1.12M -927.52% | -1.31M -470.43% | -1.80M -222.14% | -1.71M -83.37% | -1.44M -28.13% | 1.44M +209.38% | -388.00K +78.49% | -771.00K +54.89% | -871.00K +39.30% | -1.83M -227.39% | -2.25M -480.93% | -3.08M -300.13% | -8.04M -- |
Interest Expense | 38.00K -- | -- -- | -- -- | 75.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | 2.00K -- | 16.00K -- | 47.00K -- | 109.00K -- | 230.00K +11400.00% | 560.00K +3400.00% | 932.00K +1882.98% | 1.12M +927.52% | 1.31M +470.43% | 1.80M +222.14% | 1.71M +83.37% | 1.44M +28.13% | -1.44M -209.38% | 388.00K -78.49% | 771.00K -54.89% | 871.00K -39.30% | 1.83M +227.39% | 2.25M +480.93% | 3.08M +300.13% | 8.04M -- |
Pretax Income From Continuing Operations | -1.44M -- | -2.20M -- | -2.31M -- | -3.67M -- | -2.78M -93.66% | -5.78M -162.26% | -6.18M -168.05% | -8.22M -124.22% | -10.91M -292.30% | -11.99M -107.64% | -13.59M -119.73% | -15.00M -82.45% | -16.52M -51.42% | -19.02M -58.66% | -19.56M -43.97% | -20.36M -35.74% | -23.19M -40.35% | 22.60M +218.77% | -16.28M +16.80% | -30.11M -47.92% | -2.52M +89.14% | -32.13M -242.21% | -25.18M -54.67% | -31.87M -5.85% | -91.70M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 3.00K -- | -- -- | -- -- | -- -- | 25.00K +733.33% | -- -- | -- -- | -- -- | 56.00K +124.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 58.00K -- | -- -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 102.00K -- | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -44.00K -- | -- -- |
Net Income | -1.44M -- | -2.20M -- | -2.31M -- | -3.67M -- | -2.78M -93.66% | -5.78M -162.26% | -6.18M -168.05% | -8.22M -124.30% | -10.91M -292.30% | -11.99M -107.64% | -13.59M -119.73% | -15.02M -82.68% | -16.52M -51.42% | -19.02M -58.66% | -19.56M -43.97% | -20.41M -35.89% | -23.19M -40.35% | 22.60M +218.77% | -16.28M +16.80% | -30.11M -47.51% | -2.52M +89.14% | -32.13M -242.21% | -25.18M -54.67% | -31.93M -6.04% | -91.76M -- |
Net Income Attributable to Owners of the Company | -1.44M -- | -2.20M -- | -2.31M -- | -3.67M -- | -2.78M -93.66% | -5.78M -162.26% | -6.18M -168.05% | -8.22M -124.30% | -10.91M -292.30% | -11.99M -107.64% | -13.59M -119.73% | -15.02M -82.68% | -16.52M -51.42% | -19.02M -58.66% | -19.56M -43.97% | -20.41M -35.89% | -23.19M -40.35% | 22.60M +218.77% | -16.28M +16.80% | -30.11M -47.51% | -2.52M +89.14% | -32.13M -242.21% | -25.18M -54.67% | -31.93M -6.04% | -91.76M -- |
Preferred Stock Dividends | -- -- | -- -- | -- -- | 153.00K -- | -- -- | -- -- | -- -- | 22.00K -85.62% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -1.44M -- | -2.20M -- | -2.31M -- | -3.82M -- | -2.78M -93.66% | -5.78M -162.26% | -6.18M -168.05% | -8.24M -115.89% | -10.91M -292.30% | -11.99M -107.64% | -13.59M -119.73% | -15.02M -82.20% | -16.52M -51.42% | -19.02M -58.66% | -19.56M -43.97% | -20.41M -35.89% | -23.19M -40.35% | 22.60M +218.77% | -16.28M +16.80% | -30.11M -47.51% | -2.52M +89.14% | -32.13M -242.21% | -25.18M -54.67% | -31.93M -6.04% | -91.76M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -59.00K -- | -585.00K -- | -- -- | -- -- | -407.00K -589.83% | 265.00K +145.30% | -22.00K -- | -- -- | 703.00K +272.73% | -270.00K -201.89% | 270.00K +1327.27% | 0 -- | -- -- | -55.00K +79.63% | -24.00K -108.89% | 53.00K -- | 100.00K -- | 74.00K -- |
Total Comprehensive Income | -1.44M -- | -2.20M -- | -2.31M -- | -3.67M -- | -2.78M -93.66% | -5.78M -162.26% | -6.18M -168.05% | -8.28M -125.91% | -11.49M -313.34% | -11.99M -107.64% | -13.59M -119.73% | -15.43M -86.30% | -16.25M -41.41% | -19.05M -58.84% | -19.56M -43.97% | -19.71M -27.75% | -23.46M -44.30% | 22.87M +220.05% | -16.28M +16.80% | -30.11M -52.78% | -2.57M +89.03% | -32.16M -240.64% | -25.12M -54.34% | -31.83M -5.71% | -91.69M -- |
Total Comprehensive Income Attributable to Owners of the Company | -1.44M -- | -2.20M -- | -2.31M -- | -3.67M -- | -2.78M -93.66% | -5.78M -162.26% | -6.18M -168.05% | -8.28M -125.91% | -11.49M -313.34% | -11.99M -107.64% | -13.59M -119.73% | -15.43M -86.30% | -16.25M -41.41% | -19.05M -58.84% | -19.59M -44.13% | -19.95M -29.32% | -23.46M -44.30% | 22.87M +220.05% | -16.28M +16.89% | -30.11M -50.91% | -2.57M +89.03% | -32.16M -240.64% | -25.12M -54.34% | -31.83M -5.71% | -91.69M -- |
Basic EPS | -5.95 -- | -9.12 -- | -10.13 -- | -- -- | -11.49 -93.11% | -23.8 -160.96% | -0.26 +97.43% | -0.34 -- | -0.45 +96.08% | -0.49 +97.94% | -0.56 -115.38% | -0.61 -79.41% | -0.67 -48.89% | -0.76 -55.10% | -0.71 -26.79% | -0.74 -21.31% | -0.83 -23.88% | 0.78 +202.63% | -5.16 -626.76% | -1.04 -40.54% | -0.09 +89.16% | -0.86 -210.26% | -0.48 +90.70% | -0.65 +37.50% | -2.08 -- |
Basic EPS from Continuing Operations | -5.95 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.71 -- | -- -- | -0.83 -- | -- -- | -5.16 -626.76% | -- -- | -0.09 +89.16% | -0.86 -- | -0.48 +90.70% | -- -- | -- -- |
Diluted EPS | -5.95 -- | -9.12 -- | -10.13 -- | -- -- | -11.49 -93.11% | -23.8 -160.96% | -0.26 +97.43% | -- -- | -0.45 +96.08% | -0.49 +97.94% | -0.56 -115.38% | -- -- | -0.67 -48.89% | -0.76 -55.10% | -0.71 -26.79% | -- -- | -0.83 -23.88% | -- -- | -5.16 -626.76% | -- -- | -0.09 +89.16% | -0.86 -- | -0.48 +90.70% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -5.95 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.71 -- | -- -- | -0.83 -- | -- -- | -5.16 -626.76% | -- -- | -0.09 +89.16% | -0.86 -- | -0.48 +90.70% | -- -- | -- -- |
You can ask Aime
What is the market's earnings forecast for Jade Biosciences next quarter?What does Jade Biosciences do and what are its main business segments?What guidance did Jade Biosciences's management provide for the next earnings period?What is Jade Biosciences's gross profit margin?What were the key takeaways from Jade Biosciences’s earnings call?Did Jade Biosciences beat or miss consensus estimates last quarter?What factors drove the changes in Jade Biosciences's revenue and profit?What is the revenue and EPS growth rate for Jade Biosciences year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
